Trial ID or NCT#
This study is intended to establish the practicality of treating cancer in the liver with precisely administered single fractions of high-energy radiation using a radiosurgical (cross-firing) technique. A second purpose is to establish a safe dose for such therapy. Finally, the efficacy of radiosurgical ablation of liver tumors, in terms of radiographic response, will be measured.
Dose Escalation Study Evaluating Stereotactic Radiosurgery for Liver Malignancies
Contact us to find out if this trial is right for you.